e-Profile Login and ID Quick Search
Gilead Products Distributed by MIC May Be Potentially Suspect Due to Possible Tampering
Gilead Sciences, Inc is alerting pharmacies about three instances in which patients have returned bottles of Gilead products after discovering that the bottles contained a different product than the product listed on the label. In a letter (PDF) to pharmacies, Gilead provides additional details about the three instances. Gilead also indicates that “Based on our investigation, in all three cases, we have concluded that the pharmacies purchased the products that were labeled as Gilead Viread and Atripla from Minnesota Independent Cooperative (MIC). MIC does not buy product directly from Gilead, and we are unaware of the source of the product obtained by MIC.” Gilead recommends that if you have obtained Gilead product from MIC that you verify its authenticity by conducting a visual inspection, and request a pedigree for each product to determine its distribution history. Further, Gilead recommends that if pharmacies have dispensed Gilead product from MIC to patients, patients should be advised to return the product to the pharmacy for visual inspection. Any potentially suspect bottles can be reported to Gilead Medical Information by calling 800/445-3235 (select option 2) or by sending an e-mail to medicalinformation@gilead.com. Adverse events following or coincident with the use of any Gilead product may be reported to Gilead Sciences Drug Safety and Public Health by calling 800/445-3235 (select option 3), or to the Food and Drug Administration (FDA) MedWatch Program by calling 800/322-1088 or by completing on online report.
